Once a high-flying adtech darling, The Trade Desk has seen its stock crater nearly 80% from its peak amid a fierce battle with Amazon's ad juggernaut. With shares now trading at a significant discount to the market, analysts are divided on whether this marks a historic buying opportunity or signals deeper structural challenges.
Investors seeking stability in volatile markets often turn to consumer staples ETFs. We analyze the strategic divergence between Fidelity's broad, low-cost approach and Invesco's targeted, factor-driven fund to determine which might better serve a defensive portfolio.
Woodward, Inc. (WWD) kicked off fiscal 2026 with robust first-quarter results, driven by exceptional performance in commercial aerospace services and broad-based industrial growth. The company reported a 29% year-over-year sales increase and a 54% jump in EPS, prompting an upward revision to its annual guidance.
Kforce reports stronger-than-expected Q4 2025 results, citing the highest sequential growth in its tech business since 2022. The company sees early signs of a market recovery, fueled by client demand for flexible talent to tackle AI-driven projects and foundational IT work.
ExxonMobil capped 2025 with its highest annual oil and gas output in over four decades while returning historic cash to shareholders, setting the stage for a pivotal year as it balances traditional strength with energy transition investments.
Shares of New York-focused REIT Alexander's have delivered impressive returns, but a closer look reveals a widening gap between its market price and key valuation metrics, prompting debate among investors.
Crude oil and gasoline futures tumbled sharply on Monday, pressured by a rallying U.S. dollar and signs of diplomatic engagement between the U.S. and Iran. The sell-off marks a significant reversal from last week's geopolitical premium.
Fabrinet's Q2 2026 earnings reveal a historic quarter, with revenue hitting $1.13B driven by explosive growth in high-performance computing and telecom. The company signals sustained momentum with aggressive capacity expansion.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
U.S. equities found firmer ground Tuesday, buoyed by a robust factory activity report. The rally unfolded as investors grow increasingly discerning about AI-related capital expenditures, creating clear winners and losers.
Despite strong performance from the Latin American e-commerce and fintech leader, investment manager Triasima reduced its position, highlighting portfolio discipline over bearish sentiment.
Shares of the data analytics firm jumped more than 5% following a strong quarterly report that exceeded expectations and featured ambitious growth projections for the coming year.
U.S.-listed exchange-traded funds attracted $165.4 billion in January, with a notable pivot toward international stock funds as they continue to outperform domestic markets.
Palantir Technologies shatters expectations with Q4 results, reporting a 70% revenue surge and forecasting continued robust growth, as its AI platform becomes a central driver for U.S. commercial business.
A new global survey from JPMorgan Private Bank shows wealthy families remain overwhelmingly cautious on cryptocurrency investments, with a strong preference for traditional portfolio strategies despite market hype.
Walt Disney Co. shares fell sharply following a quarterly earnings report that showed a decline in profit, breaking key technical support levels. While some investors fled, Citigroup analysts see the drop as a buying opportunity for the long term.
As investors seek reliable cash flow in a volatile market, a focus on assets with strong distribution histories and growth potential remains key. Here’s a look at three income-generating investments poised for steady returns.
While long-term investing remains a cornerstone strategy, Supercomnet Technologies Berhad (KLSE:SCOMNET) serves as a stark reminder of its pitfalls. Shareholders who invested five years ago are facing a 63% total loss, starkly underperforming the broader market and raising questions about the disconnect between company performance and stock valuation.
Universal Health Services (UHS) is drawing renewed investor interest following better-than-expected quarterly results, driven by robust behavioral health demand and a significant easing of industry-wide staffing pressures. While operational improvements bolster the near-term outlook, debates persist over valuation and the company's ability to sustain gains amid high debt levels.
A detailed valuation analysis suggests Huntington Bancshares (HBAN) shares could be trading at nearly a 50% discount to their intrinsic value, despite the stock's modest performance over the past year. The findings come as investors scrutinize the resilience of U.S. regional lenders.
